"
Finance

How to Invest in CRISPR

The CRISPR technique has spurred multiple biological ventures, including those led by the scientists behind the discovery. Publicly traded biotech companies using CRISPR include CRISPR Therapeutics, whose stock trades under the “CRSP” ticker symbol, and Beam Therapeutics, whose stock trades under “BEAM.” Others are Editas Medicine, whose stock trades under “EDIT,” and Intellia Therapeutics, whose stock trades under “NTLA.”

CRISPR Therapeutics closed Thursday at $95.39. The stock is up 57 percent this year but is still trading 10 percent below its 52-week high. Meanwhile, Beam Therapeutics stock closed Thursday at $28.50. The stock has gained 52 percent in 2020 but is also 10 percent below its 52-week high. 

Editas Medicine stock closed Thursday at $30.71, up 4 percent this year but at a 20 percent discount to its 52-week peak. Finally, Intellia Therapeutics stock closed Thursday at $22.94. The stock is up 56 percent in 2020 but 12 percent below its 52-week high.

View more information: https://marketrealist.com/p/how-to-invest-in-crispr/

See more articles in category: Finance
See also  Inflammation and Immunology: Celgene’s Diversified Research Pipeline

Leave a Reply

Back to top button